Terms: = Prostate cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Staging
4 results:
1. A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.
Wit EMK; KleinJan GH; Berrens AC; van Vliet R; van Leeuwen PJ; Buckle T; Donswijk ML; Bekers EM; van Leeuwen FWB; van der Poel HG
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2861-2871. PubMed ID: 37036490
[TBL] [Abstract] [Full Text] [Related]
2. Can
Peng L; Li J; Meng C; Li J; You C; Tang D; Wei T; Xiong W; Li Y
Radiat Oncol; 2020 Oct; 15(1):227. PubMed ID: 33004037
[TBL] [Abstract] [Full Text] [Related]
3. Screening for prostate cancer in Romania.
Waidelich R; Bumbu G; Raica M; Toma M; Maghiar T; Hofstetter A
Int Urol Nephrol; 2002; 34(4):503-5. PubMed ID: 14577492
[TBL] [Abstract] [Full Text] [Related]
4. The economic burden of prostate cancer in Canada: forecasts from the Montreal prostate cancer Model.
Grover SA; Coupal L; Zowall H; Rajan R; Trachtenberg J; Elhilali M; Chetner M; Goldenberg L
CMAJ; 2000 Apr; 162(7):987-92. PubMed ID: 10763396
[TBL] [Abstract] [Full Text] [Related]
